Active Surveillance in Favorable Intermediate-Risk Prostate Cancer

James A. Eastham, MD, FACS, considers how to select candidates for active surveillance in the intermediate-risk prostate cancer population.

[@d.r.martin6301]

Would a high risk shown in a genomics test of a biopsy automatically indicate that surgery or radiation should be done? Thanks for any insights.

[@antoniodelrey164]

It going to grow sooner or later so it should be treated before it gets out of hand but what is the best and least harmful treatment? That’s the difficult question to answer. Great presentation! What is favorable is another difficult question to answer. Any DNA test such as a Decipher Code help determine what would be favorable?

[@robert7871]

What is a "positive MRI"? Positive for cancer (bad), or, positive meaning a good outcome?

[@robert7871]

Somewhat confusing. Does positive MRI mean that no lesions were identified?

[@bbkingisguitar100]

Is Pirads 3 considered a positive MRI in your presentation?

[@jamiemcneil9462]

This video illustrates that urology, when attempting to understand prostate cancer, is completely clueless.

[@eugeneano285]

is percentage not based on length?

[@harrymaier2292]

Interesting question ...
Case A)
1 Biopsy-Core 20 mm
Cancerous material 15 %
Pattern 3 (80%)
Pattern 4 (20%)
Case B)
1 Biopsy-Core 20 mm
Cancerous material 40%
Pattern 3 (90%)
Pattern 4 (10%)
Which case is more favorable for the patient ?

[@TERRY-cb2ku]

​@@harrymaier2292B

[@Delani11]

Case A